impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Aetiopathogenesis

 

Increased immunoreactivity against human cytomegalovirus UL83 in systemic sclerosis

1, 2, 3, 4, 5, 6, 7, 8, 9, 10

 

  1. Dept. Rheumatology & Clin. Immunol., School Health Sciences, Univ.of Thessaly, Larissa; and Cellular Immunotherapy & Molecular Immunodiagnostics, Biomedical Section, Ctre for Res. & Technology-Hellas (CERTH)- Inst. Research & Technology-Thessaly, Greece.
  2. Dept. Rheumatology & Clin. Immunol., School Health Sciences, Univ.of Thessaly, Larissa; and Cellular Immunotherapy & Molecular Immunodiagnostics, Biomedical Section, Ctre for Res. & Technology-Hellas (CERTH)- Inst. Research & Technology-Thessaly, Greece.
  3. Dept. Rheumatology & Clin. Immunol., School Health Sciences, Univ.of Thessaly, Larissa; and Cellular Immunotherapy & Molecular Immunodiagnostics, Biomedical Section, Ctre for Res. & Technology-Hellas (CERTH)- Inst. Research & Technology-Thessaly, Greece.
  4. Department of Neurology, University General Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
  5. Department of Gynaecology and Obstetrics, University General Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
  6. Institute of Immunology, Euroimmun, Lübeck, Germany.
  7. Institute of Immunology, Euroimmun, Lübeck, Germany.
  8. Department of Neurology, University General Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
  9. Dept. Rheumatology & Clin. Immunol., School Health Sciences, Univ.of Thessaly, Larissa; and Cellular Immunotherapy & Molecular Immunodiagnostics, Biomedical Section, Ctre for Res. & Technology-Hellas (CERTH)- Inst. Research & Technology-Thessaly, Greece.
  10. Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece. lsakkas@med.uth.gr

CER9910
2017 Vol.35, N°4 ,Suppl.106
PI 0031, PF 0034
Aetiopathogenesis

Free to view
(click on article PDF icon to read the article)

PMID: 28240591 [PubMed]

Received: 07/09/2016
Accepted : 03/01/2017
In Press: 27/02/2017
Published: 12/10/2017

Abstract

OBJECTIVES:
To study immunoreactivity against human cytomegalovirus (HCMV) in systemic sclerosis (SSc), since HCMV has been put forward as a candidate infectious cause.
METHODS:
Eighty four patients with SSc (67 females; median age 60 years, range 25-81), 30 patients with multiple sclerosis (MS) (23 females; median age 44, range 20-69 years) and 28 healthy controls (NCs), all pre-tested positive for IgG anti-HCMV antibodies, were studied. IgG anti-UL83 HCMV antibodies were tested by western immunoblotting and expressed in arbitrary units (AUs). Reactivity to UL83 HCMV was assessed in relation to clinical manifestations and SSc-related autoantibodies (autoAbs), tested by an IgG SSc autoantibody profile line immunoassay (Euroimmun) that detects autoAbs against Scl-70, CENPA, CENPB, RNA polymerase III subunit 11 (RP11), RP155, fibrillarin, NOR90, Th/To, PM-Scl100, PM-Scl75, Ku, PDGFR and Ro-52.
RESULTS:
Fifty patients (59.5%) were anti-UL83 clear positive (UL83+), including 21/40 (52.5%) lcSSc and 29/44 (65.6%) dcSSc, compared to 15/30 (50%) patients with MS (SSc vs MS, p=ns and 11/28 (39.29%) of NCs (SSc vs NC, p=ns MS vs NC, p=ns). Anti-UL83 antibody AU levels (mean±SD) were higher in SSc (64.3 ± 26) compared to MS (49.1±21.6, p=0.05) or NCs (40.4±13.7, p<0.001; MS vs NCs, p=ns) and were associated with pulmonary fibrosis.
CONCLUSIONS:
Immunoreactivity to UL83 HCMV is frequent and strong in patients with SSc, implying a possible pathogenic role for this disease.

Rheumatology Article